Status:
COMPLETED
Epicardial Fat Thickness and Inflammation in People With Metabolic Syndrome and Obesity
Lead Sponsor:
Antalya Training and Research Hospital
Conditions:
Metabolic Syndrome
Obesity
Eligibility:
All Genders
18+ years
Brief Summary
Epicardial adipose tissue (EAT) is a type of visceral adipose tissue (VAT), functioning as a metabolically active endocrine organ and suggested to play an important role in the progression of metaboli...
Detailed Description
Epicardial adipose tissue (EAT) is a kind of VAT, between the surface of the myocardium and the epicardium. It can easily be measured by standard two-dimensional (2D) echocardiography. EAT serves as a...
Eligibility Criteria
Inclusion
- \- Having body mass index ≥30 kg/m2
Exclusion
- .
- Manifest heart disease ( coronary heart disease, cardiac failure, cardiac valve disease or arrythmia)
- Renal failure
- Hepatic failure
- Infection
- Chronic systemic inflammatory disease
- Pulmonary disease
- Malignancy
- Inadequate transthoracic echocardiographic images
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2019
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT04437979
Start Date
January 1 2019
End Date
September 1 2019
Last Update
August 21 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Antalya Research and Training Hospital
Antalya, Turkey (Türkiye)